Albers Jeffrey W.

Blueprint Medicines Corp

Director

Avg. Two Year Performance

No Purchase Track Record

(18%) Avg. Sale Return (8%) Compound

Holdings: 157.56K shares

Last Three Months: 25-Aug-24 -- 24-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Insider Trading Sentiment: Reduce

Company Sentiment

Biotechnology

Drugs

Two Year Chart

25-Nov-22 -- 24-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions